Want to see DE:VBK full AI Analyst Report?
Top Page
verbio Vereinigte BioEnergie
(XETRA:VBK)
Select Model
Select Model
Rating:61Neutral
Price Target:
€32.00
▼(-0.06% Downside)
Action:Reiterated
Date:09/29/26
The score is primarily supported by improving financial performance (return to profitability and positive free cash flow) and constructive earnings-call guidance pointing to further EBITDA growth and strengthening balance sheet metrics. Offsetting this, the stock’s technical trend is weak (below major moving averages with soft momentum) and valuation looks less compelling at ~30x earnings given the company’s historical earnings and cash flow volatility.
Positive Factors
Record production and biomethane growth
Record output and the continued Nevada ramp-up indicate expanding productive capacity and improving utilization. Biomethane growth adds scale to a renewable-fuels platform with demand supported by transport decarbonization, strengthening the company’s ability to grow volumes over the coming quarters.
Negative Factors
Earnings and cash-flow cyclicality
The sharp swing from strong profitability to a 2025 loss and subsequent recovery shows that earnings remain sensitive to market cycles. Uneven cash conversion can constrain reinvestment and make future results less predictable even when operations and the balance sheet improve.
Read all positive and negative factors
Positive Factors
Negative Factors
Record production and biomethane growth
Record output and the continued Nevada ramp-up indicate expanding productive capacity and improving utilization. Biomethane growth adds scale to a renewable-fuels platform with demand supported by transport decarbonization, strengthening the company’s ability to grow volumes over the coming quarters.
Read all positive factors
verbio Vereinigte BioEnergie (VBK) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€1.82B
Dividend Yield1.68%
Average Volume (3M)83.98K
Price to Earnings (P/E)27.9
Beta (1Y)0.22
Revenue Growth18.54%
EPS GrowthN/A
CountryDE
Employees1,394
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)1.00
Shares Outstanding64,008,484
10 Day Avg. Volume109,522
30 Day Avg. Volume83,982
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)2.33
Price to Sales (P/S)1.02
P/FCF Ratio24.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€39.00Price Target Upside21.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.96
Revenue Forecast (FY)€2.00B
verbio Vereinigte BioEnergie Business Overview & Revenue Model
Company Description
VERBIO Vereinigte BioEnergie AG operates as a prominent producer and supplier of sustainable biofuels throughout Germany and the broader European market. The firm's diverse portfolio features products such as biodiesel, bioethanol, biomethane, bio...
How the Company Makes Money
VERBIO makes money primarily by producing renewable fuels and selling them into regulated fuel markets where blending mandates and greenhouse-gas (GHG) reduction schemes create demand and pricing support.
1) Sale of renewable fuels (core revenue)...
verbio Vereinigte BioEnergie Earnings Call Summary
Earnings Call Date:Sep 24, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Nov 12, 2026
Earnings Call Sentiment Positive
The call was strongly positive overall. Verbio reported a substantial EBITDA recovery, record production, strong cash generation, lower net debt, improved returns, a significantly stronger fourth quarter, and positive EBITDA guidance for 2026/2027. Management also highlighted supportive regulation, continued biomethane demand, and strategic growth projects. The main challenges were lower expected biodiesel contribution, pressure on benchmark biodiesel spreads, quota-market uncertainty, a high tax rate, and the fact that potential 45Z benefits are not included in guidance.Positive Updates
Full-Year EBITDA Recovery
Group EBITDA increased to EUR 193.9 million for financial year 2025/2026, primarily driven by normalization of the greenhouse gas quota market, improved bioethanol market spreads, higher utilization rates in North America, the reversal of impairments on greenhouse gas quota inventories, and the absence of negative one-off effects recorded in 2024/2025.
Negative Updates
Lower Expected Biodiesel Contribution
Verbio expects a somewhat lower contribution from the Biodiesel segment in financial year 2026/2027. Planning is based on market spreads below the levels seen in the past financial year and reflects remaining uncertainty around market developments and the effectiveness of anti-fraud measures.
Read all updates
Q4-2026 Updates
Positive
Negative
Full-Year EBITDA Recovery
Group EBITDA increased to EUR 193.9 million for financial year 2025/2026, primarily driven by normalization of the greenhouse gas quota market, improved bioethanol market spreads, higher utilization rates in North America, the reversal of impairments on greenhouse gas quota inventories, and the absence of negative one-off effects recorded in 2024/2025.
Read all positive updates
Company Guidance
For financial year '26, '27, Verbio expects group EBITDA to increase to between EUR 210 million and EUR 250 million, with the increase primarily volume-driven, supported by greenhouse gas earnings, higher production volumes in North America, particularly from Nevada, and continued growth in biomethane production; year-end greenhouse gas inventories at a group level are planned to be around 5% lower than at the beginning of the financial year, most purchasing of the '26 compliance year should take place during financial year '26, '27, a significant share of the related result should be recognized in the third quarter, and a large part of the earnings potential from surplus volumes in the '27 compliance year should be realized in financial year '27, '28. Greenhouse gas quota prices for calendar year 2027 were stated at approximately EUR 420, EUR 440 per tonne CO2, and the Biodiesel segment is expected to make a somewhat lower contribution than in financial year '25, '26, based on market spreads below the levels seen in the past financial year; investment spending is expected to decline, supporting strong cash generation and a further reduction in net debt. The planning includes the contribution from the ethenolysis plant, while 45Z is not reflected in the planning.verbio Vereinigte BioEnergie Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.87B | 1.58B | 1.67B | 1.97B | 1.81B |
| Gross Profit | 336.50M | 37.12M | 292.45M | 381.91M | 626.92M |
| EBITDA | 175.83M | -54.41M | 122.92M | 242.68M | 494.81M |
| Net Income | 63.92M | -138.01M | 19.96M | 132.02M | 315.63M |
Balance Sheet | |||||
| Total Assets | 1.37B | 1.28B | 1.38B | 1.30B | 1.13B |
| Cash, Cash Equivalents and Short-Term Investments | 90.30M | 64.41M | 126.70M | 170.31M | 300.50M |
| Total Debt | 221.34M | 268.86M | 194.20M | 189.97M | 49.39M |
| Total Liabilities | 552.08M | 536.78M | 449.54M | 385.36M | 310.16M |
| Stockholders Equity | 816.68M | 746.29M | 925.67M | 909.47M | 816.23M |
Cash Flow | |||||
| Free Cash Flow | 78.37M | -117.96M | -54.38M | -177.12M | 210.15M |
| Operating Cash Flow | 164.56M | 13.88M | 116.78M | 26.09M | 325.03M |
| Investing Cash Flow | -75.27M | -120.06M | -144.90M | -266.43M | -113.62M |
| Financing Cash Flow | -64.08M | 49.88M | -19.53M | 112.21M | -18.48M |
verbio Vereinigte BioEnergie Technical Analysis
Negative
32.02
Price Trends
30.63
Negative
32.13
Negative
31.21
Negative
Market Momentum
-0.49
Positive
35.01
Neutral
15.14
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Negative. The current price of 32.02 is above the 20-day moving average (MA) of 30.60, above the 50-day MA of 30.63, and above the 200-day MA of 31.21, indicating a bearish trend. The MACD of -0.49 indicates Positive momentum. The RSI at 35.01 is Neutral, neither overbought nor oversold. The STOCH value of 15.14 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:VBK.
verbio Vereinigte BioEnergie Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | €5.23B | 16.57 | 17.00% | 3.29% | 5.53% | 17.05% | |
64 Neutral | €9.25B | 78.81 | 1.49% | 4.91% | -4.03% | -71.46% | |
62 Neutral | €8.56B | 23.48 | 8.30% | 3.21% | -5.28% | -13.76% | |
61 Neutral | €1.82B | 27.92 | 8.33% | 1.68% | 18.54% | ― | |
57 Neutral | €4.37B | -10.19 | -11.14% | 2.84% | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | €1.08B | -1.63 | -18.62% | 0.79% | -9.81% | -305.46% |
* General Sector Average
DE:VBK
verbio Vereinigte BioEnergie
27.92
16.92
153.82%
DE:BNR
Brenntag AG
59.18
8.82
17.52%
DE:EVK
Evonik
20.38
6.41
45.94%
DE:FPE
Fuchs Petrolub
37.10
7.90
27.03%
DE:LXS
LANXESS
12.60
-8.64
-40.67%
DE:WCH
Wacker Chemie AG
89.95
26.20
41.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.